Related Experiment Videos
Pharmacokinetics as an aid to optimising compliance with medications
1Division of General Internal Medicine, Stanford University Medical Center, California, USA.
Clinical Pharmacokinetics
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Automatically Identifying Financial Stress Information from Clinical Notes for Patients with Prostate Cancer.
Cancer research and reports·2024
Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Deficiencies in education and experience in the management of acute kidney injury among Malawian healthcare workers.
Malawi medical journal : the journal of Medical Association of Malawi·2015
EHR Big Data Deep Phenotyping. Contribution of the IMIA Genomic Medicine Working Group.
Yearbook of medical informatics·2014
A Public Health Grid (PHGrid): Architecture and value proposition for 21st century public health.
International journal of medical informatics·2010
Internet-based monitoring of patients with rheumatoid arthritis.
Clinical and experimental rheumatology·2004
Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis.
Clinical pharmacokinetics·2026
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy. Part II: Cephalosporins.
Clinical pharmacokinetics·2026
Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.
Clinical pharmacokinetics·2026
Pharmacokinetics of IL-23p19 Inhibitors: A Systematic Review Across Immune-Mediated Inflammatory Diseases.
Clinical pharmacokinetics·2026
Evaluating seltorexant as a treatment option for major depressive disorder.
Expert review of neurotherapeutics·2026
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.
International journal of obesity (2005)·2026